Assemble labelled drug-pair data
Collect or synthesise pairwise examples with a reliable interaction label (from DrugBank, FAERS or curated sources) and split by drug pairs to avoid leakage.
Predict drug-drug interactions. Assess clinical risk trade-offs.
Drug–drug interaction (DDI) prediction seeks to estimate whether two co-administered drugs will interact harmfully. Practical work requires selecting representations for drug pairs (molecular fingerprints, interaction histories, structured ontologies), careful labelling from pharmacovigilance or curated databases, and evaluation with clinical-oriented metrics such as sensitivity, specificity and calibration.
Learning concept · Not a validated service
Drug–drug interaction (DDI) prediction seeks to estimate whether two co-administered drugs will interact harmfully. Practical work requires selecting representations for drug pairs (molecular fingerprints, interaction histories, structured ontologies), careful labelling from pharmacovigilance or curated databases, and evaluation with clinical-oriented metrics such as sensitivity, specificity and calibration.
A proposed application: a triage tool for pharmacovigilance teams that highlights likely high-risk drug pairs for human review. This prototype should not be used to make autonomous clinical decisions; a qualified reviewer must remain in charge.
Collect or synthesise pairwise examples with a reliable interaction label (from DrugBank, FAERS or curated sources) and split by drug pairs to avoid leakage.
Create pair representations such as concatenated molecular fingerprints, indication overlap, or learnt embeddings from molecular graphs.
Fit a standardised pipeline (scaling, classifier) and log hyperparameters; prefer metrics that penalise false negatives if safety is primary.
Report sensitivity, specificity, calibration error and manually inspect high-uncertainty pairs before any operational use.
The supplied starter generates a synthetic tabular classification dataset with sklearn.make_classification, places features into a pandas DataFrame, splits train/test, fits a Pipeline with StandardScaler and RandomForestClassifier, and prints a classification report on the synthetic test set. It does not load drug or molecular data, nor does it construct drug-pair features or use pharmacovigilance labels.
model = Pipeline(
steps=[
("scale", StandardScaler()),
("classifier", RandomForestClassifier(n_estimators=250, random_state=RANDOM_STATE)),
]
)
model.fit(X_train, y_train)
predictions = model.predict(X_test)The starter uses synthetic, randomly generated features from make_classification; these features are not drug descriptors or pairwise interaction signals. Consequently, reported accuracy on this toy data does not validate drug–drug interaction performance and cannot be used for clinical risk claims.
A proposed extension: replace the synthetic data with labelled drug-pair records (for example from DrugBank or curated adverse event datasets), engineer molecular and interaction features, and expose predictions through a reviewer-facing dashboard that highlights uncertain and high-risk pairs.
This is a potential application pathway, not a delivered product. The supplied starter does not implement this service or validate it with real users.
Networkers Home runs this topic inside its AI Engineer Course, with placement support and hands-on labs.